<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>AML PathwaysCAST</title>
    <link>http://www.lls.org</link>
    <description>Podcast for those living with Acute Myelogenous Leukemia (AML). Sponsored by The Leukemia &amp; Lymphoma Society.</description>
    <copyright>(c)2008</copyright>
    <managingEditor>admin@lls.org (admin@lls.org)</managingEditor>
    <language>en-us</language>
    <lastBuildDate>Sat, 25 May 2013 19:38:28 GMT</lastBuildDate>
    <generator>Hipcast RSS Feeder 1.25</generator>
    <category>Health &amp; Fitness</category>
    <atom:link href="http://lls.hipcast.com/rss/amlpathwayscast.xml" rel="self" type="application/rss+xml"/>
    <ttl>60</ttl>
    <image>
      <url>http://lls.hipcast.com/albumart/1006.1369510708.jpg</url>
      <link>http://www.lls.org</link>
      <title>AML PathwaysCAST</title>
    </image>
    <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
    <itunes:summary>Podcast for those living with Acute Myelogenous Leukemia (AML). Sponsored by The Leukemia &amp; Lymphoma Society</itunes:summary>
    <itunes:subtitle></itunes:subtitle>
    <itunes:explicit>no</itunes:explicit>
    <itunes:keywords>aml,acute,myelogenous,leukemia,cancer</itunes:keywords>
    <itunes:owner>
      <itunes:name>Samantha Mills</itunes:name>
      <itunes:email>admin@leukemia-lymphoma.org</itunes:email>
    </itunes:owner>
    <itunes:image href="http://lls.hipcast.com/albumart/1006.1369510708.jpg"/>
    <itunes:category text="Health"/>
    <itunes:category text="Science &amp; Medicine">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">f96f2f25-8d15-e217-83ed-9d0f0f590bce</guid>
      <title>Blood Cancer Treatment - Making Informed Choices - Part 1</title>
      <description><![CDATA[Date: February 26, 2013

Speaker: Stephen D. Nimer, MD

Topics:
Understanding goals of treatment for your diagnosis
Understanding your treatment options
Benefits and risks for standard treatments and investigational treatments
Key facts about clinical trials]]></description>
      <pubDate>Fri, 05 Apr 2013 20:36:21 GMT</pubDate>
      <itunes:duration>00:40:24</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</itunes:summary>
      <itunes:subtitle>Blood Cancer Treatment - Making Informed Choices - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3" type="audio/mpeg" length="9697545"/>
      <media:title>Blood Cancer Treatment - Making Informed Choices - Part 1</media:title>
      <media:text type="plain">Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</media:text>
      <media:content url="http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3" type="audio/mpeg" fileSize="9697545" duration="2424"/>
      <link>http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">d9d80d24-65e1-cfc5-168b-560c3f4c3f87</guid>
      <title>Blood Cancer Treatment - Making Informed Choices - Part 2</title>
      <description><![CDATA[Date: February 26, 2013

Speaker: Stephen D. Nimer, MD

Topics:
Understanding goals of treatment for your diagnosis
Understanding your treatment options
Benefits and risks for standard treatments and investigational treatments
Key facts about clinical trials]]></description>
      <pubDate>Fri, 05 Apr 2013 20:35:36 GMT</pubDate>
      <itunes:duration>00:14:31</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</itunes:summary>
      <itunes:subtitle>Blood Cancer Treatment - Making Informed Choices - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3" type="audio/mpeg" length="3485940"/>
      <media:title>Blood Cancer Treatment - Making Informed Choices - Part 2</media:title>
      <media:text type="plain">Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</media:text>
      <media:content url="http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3" type="audio/mpeg" fileSize="3485940" duration="871"/>
      <link>http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">e8d6f08e-261f-545c-86b2-f2942bf8d04e</guid>
      <title>AML - Emerging Treatment Strategies - Presentation</title>
      <description><![CDATA[Speaker: Wendy Stock, MD; Topics covered: Signs or symptoms of acute myeloid leukemia (AML), Blood and marrow tests used to diagnose AML, Current and emerging treatment options, Treatment side effects and strategies for side effect management, The role of clinical trials in the continuing improvement of AML treatment outcomes, Information and support resources for patients and caregivers]]></description>
      <pubDate>Mon, 20 Aug 2012 18:53:29 GMT</pubDate>
      <itunes:duration>00:44:44</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Wendy Stock, MD; Topics covered: Signs or symptoms of acute myeloid leukemia (AML), Blood and marrow tests used to diagnose AML, Current and emerging treatment options, Treatment side effects and strategies for side effect management, The role of clinical trials in the continuing improvement of AML treatment outcomes, Information and support resources for patients and caregivers</itunes:summary>
      <itunes:subtitle>AML - Emerging Treatment Strategies - Presentation</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/0e85a25e-677c-637c-39ac-6ebb986e7f4f.mp3" type="audio/mpeg" length="21472917"/>
      <media:title>AML - Emerging Treatment Strategies - Presentation</media:title>
      <media:text type="plain">Speaker: Wendy Stock, MD; Topics covered: Signs or symptoms of acute myeloid leukemia (AML), Blood and marrow tests used to diagnose AML, Current and emerging treatment options, Treatment side effects and strategies for side effect management, The role of clinical trials in the continuing improvement of AML treatment outcomes, Information and support resources for patients and caregivers</media:text>
      <media:content url="http://lls.hipcast.com/deluge/0e85a25e-677c-637c-39ac-6ebb986e7f4f.mp3" type="audio/mpeg" fileSize="21472917" duration="2684"/>
      <link>http://lls.hipcast.com/deluge/0e85a25e-677c-637c-39ac-6ebb986e7f4f.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">1f0170a5-2d0b-77d2-47e2-1125e636201a</guid>
      <title>AML - Emerging Treatment Strategies - QA Session</title>
      <description><![CDATA[Speaker: Wendy Stock, MD; Topics covered: Signs or symptoms of acute myeloid leukemia (AML), Blood and marrow tests used to diagnose AML, Current and emerging treatment options, Treatment side effects and strategies for side effect management, The role of clinical trials in the continuing improvement of AML treatment outcomes, Information and support resources for patients and caregivers]]></description>
      <pubDate>Mon, 20 Aug 2012 18:53:10 GMT</pubDate>
      <itunes:duration>00:13:56</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Wendy Stock, MD; Topics covered: Signs or symptoms of acute myeloid leukemia (AML), Blood and marrow tests used to diagnose AML, Current and emerging treatment options, Treatment side effects and strategies for side effect management, The role of clinical trials in the continuing improvement of AML treatment outcomes, Information and support resources for patients and caregivers</itunes:summary>
      <itunes:subtitle>AML - Emerging Treatment Strategies - QA Session</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/526db0ab-c697-c4a1-0186-b03ad507fb01.mp3" type="audio/mpeg" length="6687610"/>
      <media:title>AML - Emerging Treatment Strategies - QA Session</media:title>
      <media:text type="plain">Speaker: Wendy Stock, MD; Topics covered: Signs or symptoms of acute myeloid leukemia (AML), Blood and marrow tests used to diagnose AML, Current and emerging treatment options, Treatment side effects and strategies for side effect management, The role of clinical trials in the continuing improvement of AML treatment outcomes, Information and support resources for patients and caregivers</media:text>
      <media:content url="http://lls.hipcast.com/deluge/526db0ab-c697-c4a1-0186-b03ad507fb01.mp3" type="audio/mpeg" fileSize="6687610" duration="836"/>
      <link>http://lls.hipcast.com/deluge/526db0ab-c697-c4a1-0186-b03ad507fb01.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">3f67f513-9296-652d-4b0d-e05872887bea</guid>
      <title>AML - Emerging Treatment Strategies - Extended QA</title>
      <description><![CDATA[Speaker: Wendy Stock, MD; Topics covered: Signs or symptoms of acute myeloid leukemia (AML), Blood and marrow tests used to diagnose AML, Current and emerging treatment options, Treatment side effects and strategies for side effect management, The role of clinical trials in the continuing improvement of AML treatment outcomes, Information and support resources for patients and caregivers]]></description>
      <pubDate>Mon, 20 Aug 2012 18:52:50 GMT</pubDate>
      <itunes:duration>00:19:56</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Wendy Stock, MD; Topics covered: Signs or symptoms of acute myeloid leukemia (AML), Blood and marrow tests used to diagnose AML, Current and emerging treatment options, Treatment side effects and strategies for side effect management, The role of clinical trials in the continuing improvement of AML treatment outcomes, Information and support resources for patients and caregivers</itunes:summary>
      <itunes:subtitle>AML - Emerging Treatment Strategies - Extended QA</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/21f838cb-4def-b08e-4d3c-0cdd5701a75f.mp3" type="audio/mpeg" length="9569439"/>
      <media:title>AML - Emerging Treatment Strategies - Extended QA</media:title>
      <media:text type="plain">Speaker: Wendy Stock, MD; Topics covered: Signs or symptoms of acute myeloid leukemia (AML), Blood and marrow tests used to diagnose AML, Current and emerging treatment options, Treatment side effects and strategies for side effect management, The role of clinical trials in the continuing improvement of AML treatment outcomes, Information and support resources for patients and caregivers</media:text>
      <media:content url="http://lls.hipcast.com/deluge/21f838cb-4def-b08e-4d3c-0cdd5701a75f.mp3" type="audio/mpeg" fileSize="9569439" duration="1196"/>
      <link>http://lls.hipcast.com/deluge/21f838cb-4def-b08e-4d3c-0cdd5701a75f.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">43a03c82-0c6a-1817-211c-961c96bda5ad</guid>
      <title>AML Update: Treatment and Side Effects-Part 2</title>
      <description><![CDATA[This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. 

This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Cephalon Oncology.]]></description>
      <pubDate>Thu, 17 Feb 2011 21:55:38 GMT</pubDate>
      <itunes:duration>00:27:23</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Cephalon Oncology.</itunes:summary>
      <itunes:subtitle>AML Update: Treatment and Side Effects-Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/99cdf6de-a25c-6dab-190d-2c5137bb94e2.mp3" type="audio/mpeg" length="6570479"/>
      <media:title>AML Update: Treatment and Side Effects-Part 2</media:title>
      <media:text type="plain">This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Cephalon Oncology.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/99cdf6de-a25c-6dab-190d-2c5137bb94e2.mp3" type="audio/mpeg" fileSize="6570479" duration="1643"/>
      <link>http://lls.hipcast.com/deluge/99cdf6de-a25c-6dab-190d-2c5137bb94e2.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">d3a1539c-1bb1-459a-0133-1be98f6ad695</guid>
      <title>AML Update: Treatment and Side Effects-Part 1</title>
      <description><![CDATA[This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. 

This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Cephalon Oncology.]]></description>
      <pubDate>Thu, 17 Feb 2011 21:54:53 GMT</pubDate>
      <itunes:duration>00:26:36</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Cephalon Oncology.</itunes:summary>
      <itunes:subtitle>AML Update: Treatment and Side Effects-Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/67693536-3d75-9eb7-d38b-f9aec259fb09.mp3" type="audio/mpeg" length="6384455"/>
      <media:title>AML Update: Treatment and Side Effects-Part 1</media:title>
      <media:text type="plain">This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Cephalon Oncology.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/67693536-3d75-9eb7-d38b-f9aec259fb09.mp3" type="audio/mpeg" fileSize="6384455" duration="1596"/>
      <link>http://lls.hipcast.com/deluge/67693536-3d75-9eb7-d38b-f9aec259fb09.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">ea0a9698-a397-9bb6-e848-1703f2932f2a</guid>
      <title>Getting the Answers You Need: Fatigue and Other Cancer Treatment</title>
      <description><![CDATA[Getting the Answers You Need: Fatigue and Other Cancer Treatment
October 20, 2010

This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia & Lymphoma Society.

This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec.

Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf]]></description>
      <pubDate>Wed, 03 Nov 2010 19:26:19 GMT</pubDate>
      <itunes:duration>00:56:55</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Getting the Answers You Need: Fatigue and Other Cancer Treatment&#13;
October 20, 2010&#13;
&#13;
This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf</itunes:summary>
      <itunes:subtitle>Getting the Answers You Need: Fatigue and Other Cancer Treatment</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3" type="audio/mpeg" length="13659975"/>
      <media:title>Getting the Answers You Need: Fatigue and Other Cancer Treatment</media:title>
      <media:text type="plain">Getting the Answers You Need: Fatigue and Other Cancer Treatment&#13;
October 20, 2010&#13;
&#13;
This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf</media:text>
      <media:content url="http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3" type="audio/mpeg" fileSize="13659975" duration="3415"/>
      <link>http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">d3b090bc-c0d9-2cd7-38b5-f25975372aee</guid>
      <title>Navigating Employment and Insurance</title>
      <description><![CDATA[June 30, 2010

Navigating Employment and Insurance

This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society.

This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec.

Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt]]></description>
      <pubDate>Fri, 16 Jul 2010 18:21:10 GMT</pubDate>
      <itunes:duration>00:51:40</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 30, 2010&#13;
&#13;
Navigating Employment and Insurance&#13;
&#13;
This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt</itunes:summary>
      <itunes:subtitle>Navigating Employment and Insurance</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3" type="audio/mpeg" length="12399096"/>
      <media:title>Navigating Employment and Insurance</media:title>
      <media:text type="plain">June 30, 2010&#13;
&#13;
Navigating Employment and Insurance&#13;
&#13;
This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt</media:text>
      <media:content url="http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3" type="audio/mpeg" fileSize="12399096" duration="3100"/>
      <link>http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">b63aec75-2f46-9eb1-b6bc-cd99765ebd27</guid>
      <title>Partners in Progress: An Expert Panel Discussion - Part 2</title>
      <description><![CDATA[June 22, 2010 - Part 2

Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers

This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.
 
This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.]]></description>
      <pubDate>Fri, 09 Jul 2010 16:07:05 GMT</pubDate>
      <itunes:duration>00:59:54</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 22, 2010 - Part 2&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</itunes:summary>
      <itunes:subtitle>Partners in Progress: An Expert Panel Discussion - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3" type="audio/mpeg" length="14377715"/>
      <media:title>Partners in Progress: An Expert Panel Discussion - Part 2</media:title>
      <media:text type="plain">June 22, 2010 - Part 2&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3" type="audio/mpeg" fileSize="14377715" duration="3594"/>
      <link>http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">e58238b2-9f8c-10e5-218a-adb5d59eeeb2</guid>
      <title>Partners in Progress: An Expert Panel Discussion - Part 1</title>
      <description><![CDATA[June 22, 2010 - Part 1

Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers

This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.
 
This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.]]></description>
      <pubDate>Fri, 09 Jul 2010 16:05:59 GMT</pubDate>
      <itunes:duration>00:53:18</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 22, 2010 - Part 1&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</itunes:summary>
      <itunes:subtitle>Partners in Progress: An Expert Panel Discussion - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3" type="audio/mpeg" length="12792605"/>
      <media:title>Partners in Progress: An Expert Panel Discussion - Part 1</media:title>
      <media:text type="plain">June 22, 2010 - Part 1&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3" type="audio/mpeg" fileSize="12792605" duration="3198"/>
      <link>http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">41a73c59-8533-9b3c-219f-b575c94e28cb</guid>
      <title>Understanding AML: From Diagnosis to Treatment</title>
      <description><![CDATA[November 24, 2009

This program featured Elihu H. Estey, MD, Professor of Medicine, Division of Hematology, University of Washington School of Medicine, Member, Fred Hutchinson Cancer Research Center, Seattle, WA,  Adjunct Professor, The University of Texas, M. D. Anderson Cancer Center, Houston, TX.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by a grant from Cephalon Oncology.]]></description>
      <pubDate>Tue, 08 Dec 2009 17:34:32 GMT</pubDate>
      <itunes:duration>00:53:03</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>November 24, 2009&#13;
&#13;
This program featured Elihu H. Estey, MD, Professor of Medicine, Division of Hematology, University of Washington School of Medicine, Member, Fred Hutchinson Cancer Research Center, Seattle, WA,  Adjunct Professor, The University of Texas, M. D. Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by a grant from Cephalon Oncology.</itunes:summary>
      <itunes:subtitle>Understanding AML: From Diagnosis to Treatment</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/a0ebc1e2-b218-a86c-5250-8c5e2ddd6b61.mp3" type="audio/mpeg" length="12733464"/>
      <media:title>Understanding AML: From Diagnosis to Treatment</media:title>
      <media:text type="plain">November 24, 2009&#13;
&#13;
This program featured Elihu H. Estey, MD, Professor of Medicine, Division of Hematology, University of Washington School of Medicine, Member, Fred Hutchinson Cancer Research Center, Seattle, WA,  Adjunct Professor, The University of Texas, M. D. Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by a grant from Cephalon Oncology.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/a0ebc1e2-b218-a86c-5250-8c5e2ddd6b61.mp3" type="audio/mpeg" fileSize="12733464" duration="3183"/>
      <link>http://lls.hipcast.com/deluge/a0ebc1e2-b218-a86c-5250-8c5e2ddd6b61.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">ae02342e-c631-02d9-93d0-a63125185f62</guid>
      <title>Emerging Therapies in Leukemia, Lymphoma &amp; Myeloma</title>
      <description><![CDATA[Emerging Therapies in Leukemia, Lymphoma & Myeloma
June 16, 2009

This program featured Gail J. Roboz, MD, Associate Professor of Medicine, Director, Leukemia Program, Weill Medical College of Cornell University/New York-Presbyterian Hospital, New York, NY and John P. Leonard, MD, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Professor of Medicine, Weill Medical College of Cornell University/New York-Presbyterian Hospital, Clinical Director, New York - Cornell Center for Lymphoma and Myeloma, New York, NY and Robert Z. Orlowski, MD, PhD, Director, Myeloma Section, Associate Professor, Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX.

This program was supported in part by Celgene.]]></description>
      <pubDate>Fri, 19 Jun 2009 15:14:50 GMT</pubDate>
      <itunes:duration>01:28:06</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Emerging Therapies in Leukemia, Lymphoma &amp; Myeloma&#13;
June 16, 2009&#13;
&#13;
This program featured Gail J. Roboz, MD, Associate Professor of Medicine, Director, Leukemia Program, Weill Medical College of Cornell University/New York-Presbyterian Hospital, New York, NY and John P. Leonard, MD, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Professor of Medicine, Weill Medical College of Cornell University/New York-Presbyterian Hospital, Clinical Director, New York - Cornell Center for Lymphoma and Myeloma, New York, NY and Robert Z. Orlowski, MD, PhD, Director, Myeloma Section, Associate Professor, Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was supported in part by Celgene.</itunes:summary>
      <itunes:subtitle>Emerging Therapies in Leukemia, Lymphoma &amp; Myeloma</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/4f31d558-f1fd-71d6-8dd3-78a10824d6e8.mp3" type="audio/mpeg" length="21142593"/>
      <media:title>Emerging Therapies in Leukemia, Lymphoma &amp; Myeloma</media:title>
      <media:text type="plain">Emerging Therapies in Leukemia, Lymphoma &amp; Myeloma&#13;
June 16, 2009&#13;
&#13;
This program featured Gail J. Roboz, MD, Associate Professor of Medicine, Director, Leukemia Program, Weill Medical College of Cornell University/New York-Presbyterian Hospital, New York, NY and John P. Leonard, MD, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Professor of Medicine, Weill Medical College of Cornell University/New York-Presbyterian Hospital, Clinical Director, New York - Cornell Center for Lymphoma and Myeloma, New York, NY and Robert Z. Orlowski, MD, PhD, Director, Myeloma Section, Associate Professor, Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was supported in part by Celgene.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/4f31d558-f1fd-71d6-8dd3-78a10824d6e8.mp3" type="audio/mpeg" fileSize="21142593" duration="5286"/>
      <link>http://lls.hipcast.com/deluge/4f31d558-f1fd-71d6-8dd3-78a10824d6e8.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">d160cc57-9a09-0743-d57c-2e2b74a90d2f</guid>
      <title>AML: Emerging Treatment Approaches - Part 2</title>
      <description><![CDATA[Acute Myelogenous Leukemia (AML): Emerging Treatment Approaches

April 15, 2009 - Part 2 (Q&A)

This program featured Judith E. Karp, MD, Professor of Oncology and Medicine, Director, Leukemia Program, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, MD.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Eisai.]]></description>
      <pubDate>Tue, 26 May 2009 20:10:00 GMT</pubDate>
      <itunes:duration>00:27:59</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Acute Myelogenous Leukemia (AML): Emerging Treatment Approaches&#13;
&#13;
April 15, 2009 - Part 2 (Q&amp;A)&#13;
&#13;
This program featured Judith E. Karp, MD, Professor of Oncology and Medicine, Director, Leukemia Program, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, MD.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Eisai.</itunes:summary>
      <itunes:subtitle>AML: Emerging Treatment Approaches - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/e765673a-a2d1-4c4e-77e5-f54402b4ef7b.mp3" type="audio/mpeg" length="6714224"/>
      <media:title>AML: Emerging Treatment Approaches - Part 2</media:title>
      <media:text type="plain">Acute Myelogenous Leukemia (AML): Emerging Treatment Approaches&#13;
&#13;
April 15, 2009 - Part 2 (Q&amp;A)&#13;
&#13;
This program featured Judith E. Karp, MD, Professor of Oncology and Medicine, Director, Leukemia Program, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, MD.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Eisai.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/e765673a-a2d1-4c4e-77e5-f54402b4ef7b.mp3" type="audio/mpeg" fileSize="6714224" duration="1679"/>
      <link>http://lls.hipcast.com/deluge/e765673a-a2d1-4c4e-77e5-f54402b4ef7b.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">b7f7f3e3-44ff-c814-7ae5-38bb584f272f</guid>
      <title>AML: Emerging Treatment Approaches - Part 1</title>
      <description><![CDATA[Acute Myelogenous Leukemia (AML): Emerging Treatment Approaches

April 15, 2009 - Part 1 (Presentation)

This program featured Judith E. Karp, MD, Professor of Oncology and Medicine, Director, Leukemia Program, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, MD.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Eisai.]]></description>
      <pubDate>Tue, 26 May 2009 20:06:14 GMT</pubDate>
      <itunes:duration>00:26:10</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Acute Myelogenous Leukemia (AML): Emerging Treatment Approaches&#13;
&#13;
April 15, 2009 - Part 1 (Presentation)&#13;
&#13;
This program featured Judith E. Karp, MD, Professor of Oncology and Medicine, Director, Leukemia Program, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, MD.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Eisai.</itunes:summary>
      <itunes:subtitle>AML: Emerging Treatment Approaches - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/60da77e7-f4c2-ee38-7965-9acb4852eef8.mp3" type="audio/mpeg" length="6280801"/>
      <media:title>AML: Emerging Treatment Approaches - Part 1</media:title>
      <media:text type="plain">Acute Myelogenous Leukemia (AML): Emerging Treatment Approaches&#13;
&#13;
April 15, 2009 - Part 1 (Presentation)&#13;
&#13;
This program featured Judith E. Karp, MD, Professor of Oncology and Medicine, Director, Leukemia Program, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, MD.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Eisai.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/60da77e7-f4c2-ee38-7965-9acb4852eef8.mp3" type="audio/mpeg" fileSize="6280801" duration="1570"/>
      <link>http://lls.hipcast.com/deluge/60da77e7-f4c2-ee38-7965-9acb4852eef8.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">709e8ea8-8277-3244-f084-4c4f8b3dc770</guid>
      <title>AML: Current and Emerging Therapies</title>
      <description><![CDATA[Acute Myelogenous Leukemia: Understanding Current and Emerging Therapies

This program featured Frederick Appelbaum, M.D., Professor and Head, Division of Medical Oncology, Director, Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington Medical Center, Seattle, WA.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Eisai.]]></description>
      <pubDate>Tue, 09 Dec 2008 17:48:09 GMT</pubDate>
      <itunes:duration>00:54:37</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Acute Myelogenous Leukemia: Understanding Current and Emerging Therapies&#13;
&#13;
This program featured Frederick Appelbaum, M.D., Professor and Head, Division of Medical Oncology, Director, Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington Medical Center, Seattle, WA.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Eisai.</itunes:summary>
      <itunes:subtitle>AML: Current and Emerging Therapies</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/055a40d4-76f5-99d5-9386-89bc471f31ae.mp3" type="audio/mpeg" length="13107015"/>
      <media:title>AML: Current and Emerging Therapies</media:title>
      <media:text type="plain">Acute Myelogenous Leukemia: Understanding Current and Emerging Therapies&#13;
&#13;
This program featured Frederick Appelbaum, M.D., Professor and Head, Division of Medical Oncology, Director, Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington Medical Center, Seattle, WA.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Eisai.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/055a40d4-76f5-99d5-9386-89bc471f31ae.mp3" type="audio/mpeg" fileSize="13107015" duration="3277"/>
      <link>http://lls.hipcast.com/deluge/055a40d4-76f5-99d5-9386-89bc471f31ae.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">9fb94aca-3357-3aa6-4f41-9911469b73b1</guid>
      <title>Childhood Cancer Survivorship: The Family's Journey Forward</title>
      <description><![CDATA[5/29/2008

This program featured Nancy F. Cincotta, M.S.W., L.C.S.W., A.C.S.W., B.C.D., psychosocial director, Camp Sunshine, Casco, ME.

This program was sponsored by The Leukemia & Lymphoma Society.]]></description>
      <pubDate>Thu, 12 Jun 2008 16:03:13 GMT</pubDate>
      <itunes:duration>00:58:53</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>5/29/2008&#13;
&#13;
This program featured Nancy F. Cincotta, M.S.W., L.C.S.W., A.C.S.W., B.C.D., psychosocial director, Camp Sunshine, Casco, ME.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.</itunes:summary>
      <itunes:subtitle>Childhood Cancer Survivorship: The Family's Journey Forward</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/ab7152f1-a4a5-ed33-9f6d-c2e44651447c.mp3" type="audio/mpeg" length="14132895"/>
      <media:title>Childhood Cancer Survivorship: The Family's Journey Forward</media:title>
      <media:text type="plain">5/29/2008&#13;
&#13;
This program featured Nancy F. Cincotta, M.S.W., L.C.S.W., A.C.S.W., B.C.D., psychosocial director, Camp Sunshine, Casco, ME.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/ab7152f1-a4a5-ed33-9f6d-c2e44651447c.mp3" type="audio/mpeg" fileSize="14132895" duration="3533"/>
      <link>http://lls.hipcast.com/deluge/ab7152f1-a4a5-ed33-9f6d-c2e44651447c.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">b29b7988-c116-83f0-dab1-d995e9e998b7</guid>
      <title>Stem Cell Transplantation: Current Trends/Future Directions</title>
      <description><![CDATA[2/21/2008

This program featured Armand Keating, MD, FRCP(C), Professor of Medicine, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation at the University of Toronto.  Director, Cell Therapy Program at Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Ontario, Canada.

This program was sponsored by The Leukemia and Lymphoma Society.

Click here for the direct link to the audio:
http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3]]></description>
      <pubDate>Mon, 05 May 2008 16:02:00 GMT</pubDate>
      <itunes:duration>00:58:44</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>2/21/2008&#13;
&#13;
This program featured Armand Keating, MD, FRCP(C), Professor of Medicine, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation at the University of Toronto.  Director, Cell Therapy Program at Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Ontario, Canada.&#13;
&#13;
This program was sponsored by The Leukemia and Lymphoma Society.&#13;
&#13;
Click here for the direct link to the audio:&#13;
http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3</itunes:summary>
      <itunes:subtitle>Stem Cell Transplantation: Current Trends/Future Directions</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3" type="audio/mpeg" length="14097369"/>
      <media:title>Stem Cell Transplantation: Current Trends/Future Directions</media:title>
      <media:text type="plain">2/21/2008&#13;
&#13;
This program featured Armand Keating, MD, FRCP(C), Professor of Medicine, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation at the University of Toronto.  Director, Cell Therapy Program at Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Ontario, Canada.&#13;
&#13;
This program was sponsored by The Leukemia and Lymphoma Society.&#13;
&#13;
Click here for the direct link to the audio:&#13;
http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3" type="audio/mpeg" fileSize="14097369" duration="3524"/>
      <link>http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">d7f57342-a983-3f69-9ab0-a8cdc57ed78f</guid>
      <title>Sexuality and Intimacy After Cancer</title>
      <description><![CDATA[3/11/2008

This program featured Sage Bolte, MSW, LCSW, OSW-C, Oncology Counselor, Breast Cancer Program, Life with Cancer® Inova Cancer Services in Fairfax, Virginia.

This program was supported by The Leukemia and Lymphoma Society.

Alternate link to the audio:
http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3]]></description>
      <pubDate>Fri, 28 Mar 2008 17:09:59 GMT</pubDate>
      <itunes:duration>00:58:39</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>3/11/2008&#13;
&#13;
This program featured Sage Bolte, MSW, LCSW, OSW-C, Oncology Counselor, Breast Cancer Program, Life with Cancer® Inova Cancer Services in Fairfax, Virginia.&#13;
&#13;
This program was supported by The Leukemia and Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3</itunes:summary>
      <itunes:subtitle>Sexuality and Intimacy After Cancer</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3" type="audio/mpeg" length="14075426"/>
      <media:title>Sexuality and Intimacy After Cancer</media:title>
      <media:text type="plain">3/11/2008&#13;
&#13;
This program featured Sage Bolte, MSW, LCSW, OSW-C, Oncology Counselor, Breast Cancer Program, Life with Cancer® Inova Cancer Services in Fairfax, Virginia.&#13;
&#13;
This program was supported by The Leukemia and Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3" type="audio/mpeg" fileSize="14075426" duration="3519"/>
      <link>http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">42aceb0c-7027-31e8-13d0-bec543e78fb6</guid>
      <title>Stem Cell Transplantation: Making an Informed Choice</title>
      <description><![CDATA[02/02/06

This free telephone education program took place on Thursday, Feb. 2, 2006. The program featured Armand Keating, M.D., professor and head, Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute, Toronto, ON. 

This program was sponsored by The Leukemia & Lymphoma Society in collaboration with the National Marrow Donor Program and was supported through an educational grant from Amgen. 

Alternate link to the audio:
http://lls.audioblog.com/download/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3]]></description>
      <pubDate>Wed, 27 Feb 2008 15:38:18 GMT</pubDate>
      <itunes:duration>00:51:01</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>02/02/06&#13;
&#13;
This free telephone education program took place on Thursday, Feb. 2, 2006. The program featured Armand Keating, M.D., professor and head, Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute, Toronto, ON. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with the National Marrow Donor Program and was supported through an educational grant from Amgen. &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3</itunes:summary>
      <itunes:subtitle>Stem Cell Transplantation: Making an Informed Choice</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3" type="audio/mpeg" length="12244226"/>
      <media:title>Stem Cell Transplantation: Making an Informed Choice</media:title>
      <media:text type="plain">02/02/06&#13;
&#13;
This free telephone education program took place on Thursday, Feb. 2, 2006. The program featured Armand Keating, M.D., professor and head, Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute, Toronto, ON. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with the National Marrow Donor Program and was supported through an educational grant from Amgen. &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3" type="audio/mpeg" fileSize="12244226" duration="3061"/>
      <link>http://lls.hipcast.com/deluge/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">0767b128-b626-89cd-a2d8-b62ece30e396</guid>
      <title>New Perspectives on Stem Cell Transplantation</title>
      <description><![CDATA[06/21/07

This program featured Rainer F. Storb, M.D., head, Transplantation Biology Program at the Fred Hutchinson Cancer Research Program in Seattle, WA.

Alternate link to the audio:
http://lls.hipcast.com/download/f872eaf3-1682-a5f7-9569-935f7133162c.mp3]]></description>
      <pubDate>Wed, 27 Feb 2008 15:37:28 GMT</pubDate>
      <itunes:duration>00:53:40</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>06/21/07&#13;
&#13;
This program featured Rainer F. Storb, M.D., head, Transplantation Biology Program at the Fred Hutchinson Cancer Research Program in Seattle, WA.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/f872eaf3-1682-a5f7-9569-935f7133162c.mp3</itunes:summary>
      <itunes:subtitle>New Perspectives on Stem Cell Transplantation</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/f872eaf3-1682-a5f7-9569-935f7133162c.mp3" type="audio/mpeg" length="12880794"/>
      <media:title>New Perspectives on Stem Cell Transplantation</media:title>
      <media:text type="plain">06/21/07&#13;
&#13;
This program featured Rainer F. Storb, M.D., head, Transplantation Biology Program at the Fred Hutchinson Cancer Research Program in Seattle, WA.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/f872eaf3-1682-a5f7-9569-935f7133162c.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/f872eaf3-1682-a5f7-9569-935f7133162c.mp3" type="audio/mpeg" fileSize="12880794" duration="3220"/>
      <link>http://lls.hipcast.com/deluge/f872eaf3-1682-a5f7-9569-935f7133162c.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">8b88e963-74c7-5529-103d-b10f6ebf7a20</guid>
      <title>Practical Tips for Managing Your Finances and Insurance 2</title>
      <description><![CDATA[11/28/07

Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 2 Q&A Session

This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia & Lymphoma Society, White Plains, NY.  

This program was sponsored by The Leukemia & Lymphoma Society.

Alternate link to the audio:
http://lls.hipcast.com/download/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3]]></description>
      <pubDate>Wed, 27 Feb 2008 15:36:47 GMT</pubDate>
      <itunes:duration>00:23:15</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 2 Q&amp;A Session&#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3</itunes:summary>
      <itunes:subtitle>Practical Tips for Managing Your Finances and Insurance 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3" type="audio/mpeg" length="5581764"/>
      <media:title>Practical Tips for Managing Your Finances and Insurance 2</media:title>
      <media:text type="plain">11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 2 Q&amp;A Session&#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3" type="audio/mpeg" fileSize="5581764" duration="1395"/>
      <link>http://lls.hipcast.com/deluge/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">66751c70-04de-9ee2-44c3-03851463148c</guid>
      <title>Practical Tips for Managing Your Finances and Insurance 1</title>
      <description><![CDATA[11/28/07

Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 1 of 2 

This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia & Lymphoma Society, White Plains, NY.  

This program was sponsored by The Leukemia & Lymphoma Society.

Alternate link to the audio:
http://lls.hipcast.com/download/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3]]></description>
      <pubDate>Wed, 27 Feb 2008 15:36:08 GMT</pubDate>
      <itunes:duration>00:34:01</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 1 of 2 &#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3</itunes:summary>
      <itunes:subtitle>Practical Tips for Managing Your Finances and Insurance 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3" type="audio/mpeg" length="8164961"/>
      <media:title>Practical Tips for Managing Your Finances and Insurance 1</media:title>
      <media:text type="plain">11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 1 of 2 &#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3" type="audio/mpeg" fileSize="8164961" duration="2041"/>
      <link>http://lls.hipcast.com/deluge/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">981e6e47-52b1-9f72-ba8b-776da27ab857</guid>
      <title>AML: Current and Emerging Therapies</title>
      <description><![CDATA[01/25/07

Acute Myelogenous Leukemia (AML): Current and Emerging Therapy Options

This program featured Frederick Appelbaum, M.D., professor and head, Division of Medical Oncology, director, Clinical Research Division, Fred Hutchinson Cancer Center from the University of Washington Medical Center in Seattle, WA. 

This program was sponsored by The Leukemia & Lymphoma Society and supported by an unrestricted educational grant from Cephalon Oncology.

Alternate link to the audio:
http://lls.hipcast.com/download/5a5c5590-33c5-6213-770e-604983b516aa.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 21:14:00 GMT</pubDate>
      <itunes:duration>00:56:21</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>01/25/07&#13;
&#13;
Acute Myelogenous Leukemia (AML): Current and Emerging Therapy Options&#13;
&#13;
This program featured Frederick Appelbaum, M.D., professor and head, Division of Medical Oncology, director, Clinical Research Division, Fred Hutchinson Cancer Center from the University of Washington Medical Center in Seattle, WA. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an unrestricted educational grant from Cephalon Oncology.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/5a5c5590-33c5-6213-770e-604983b516aa.mp3</itunes:summary>
      <itunes:subtitle>AML: Current and Emerging Therapies</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/5a5c5590-33c5-6213-770e-604983b516aa.mp3" type="audio/mpeg" length="13525891"/>
      <media:title>AML: Current and Emerging Therapies</media:title>
      <media:text type="plain">01/25/07&#13;
&#13;
Acute Myelogenous Leukemia (AML): Current and Emerging Therapy Options&#13;
&#13;
This program featured Frederick Appelbaum, M.D., professor and head, Division of Medical Oncology, director, Clinical Research Division, Fred Hutchinson Cancer Center from the University of Washington Medical Center in Seattle, WA. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an unrestricted educational grant from Cephalon Oncology.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/5a5c5590-33c5-6213-770e-604983b516aa.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/5a5c5590-33c5-6213-770e-604983b516aa.mp3" type="audio/mpeg" fileSize="13525891" duration="3381"/>
      <link>http://lls.hipcast.com/deluge/5a5c5590-33c5-6213-770e-604983b516aa.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">b3bc5816-cb56-f09e-26f2-2336f4c93a3f</guid>
      <title>(AML): Understanding Treatment Approaches</title>
      <description><![CDATA[10/18/07

This program featured Jacob M. Rowe, MD, Director, Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Technion, Israel Institute of Technology, Haifa, Israel.  

This program was sponsored by The Leukemia & Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Genzyme Oncology.

Alternate link to the audio:
http://lls.hipcast.com/download/da9dcc28-ae4d-3db5-b384-6d7f80b01417.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 21:12:28 GMT</pubDate>
      <itunes:duration>00:57:11</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>10/18/07&#13;
&#13;
This program featured Jacob M. Rowe, MD, Director, Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Technion, Israel Institute of Technology, Haifa, Israel.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Genzyme Oncology.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/da9dcc28-ae4d-3db5-b384-6d7f80b01417.mp3</itunes:summary>
      <itunes:subtitle>(AML): Understanding Treatment Approaches</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/da9dcc28-ae4d-3db5-b384-6d7f80b01417.mp3" type="audio/mpeg" length="13724027"/>
      <media:title>(AML): Understanding Treatment Approaches</media:title>
      <media:text type="plain">10/18/07&#13;
&#13;
This program featured Jacob M. Rowe, MD, Director, Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Technion, Israel Institute of Technology, Haifa, Israel.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Genzyme Oncology.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/da9dcc28-ae4d-3db5-b384-6d7f80b01417.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/da9dcc28-ae4d-3db5-b384-6d7f80b01417.mp3" type="audio/mpeg" fileSize="13724027" duration="3431"/>
      <link>http://lls.hipcast.com/deluge/da9dcc28-ae4d-3db5-b384-6d7f80b01417.mp3</link>
    </item>
  </channel>
</rss>
